Jim Cramer on Medtronic (MDT): “I Think That Everything They’ve Been Doing Lately Is Right”

What: Jim Cramer praises Medtronic (MDT), stating they're making the right moves.
Why: Cramer cites Medtronic's recent efforts to expand their product offerings and improve operational efficiency.
Signal: Medtronic's stock price has risen **15%** over the past quarter, indicating a positive market reaction to their strategies.
Target: Analysts expect Medtronic's revenue to reach **$31.5 billion** in 2026, driven by growth in their minimally invasive therapies segment.
Risk: Medtronic faces intense competition in the medical device market, which may impact their ability to maintain market share and revenue growth.